Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grauer

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2025
Prognostic value of [<sup>18</sup>F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumorsMichael Müther, Lorenz König, Philipp Backhaus, et al.
Scientific Reports|April 27, 2022
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomasCüneyt Sönmez, Johannes Wölfer, Markus Holling, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 26, 2014
Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluationJuliane Schroeteler, Ralf Reeker, Eric Suero Molina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2022
Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRIClaudia Foray, Cristina Barca, Alexandra Winkeler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
TLR ligands in the local treatment of established intracerebral murine gliomasOliver M Grauer, Johan W Molling, Erik Bennink, et al.
Plos One|October 21, 2015
Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular MechanismsVerena Leidgens, Corinna Seliger, Birgit Jachnik, et al.
International Journal of Cancer|February 23, 2007
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivoOliver M Grauer, Stefan Nierkens, Erik Bennink, et al.
Frontiers in Immunology|December 24, 2021
The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke)Cristina Barca, Claudia Foray, Sven Hermann, et al.
Cancer Research and Treatment|July 27, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic LeukemiaMathias Lutz, Arik B Schulze, Elisabeth Rebber, et al.
International Journal of Cancer|December 14, 2007
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma modelOliver M Grauer, Roger P M Sutmuller, Wendy van Maren, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2025
Prognostic value of [<sup>18</sup>F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumorsMichael Müther, Lorenz König, Philipp Backhaus, et al.
Scientific Reports|April 27, 2022
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomasCüneyt Sönmez, Johannes Wölfer, Markus Holling, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 26, 2014
Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluationJuliane Schroeteler, Ralf Reeker, Eric Suero Molina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2022
Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRIClaudia Foray, Cristina Barca, Alexandra Winkeler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
TLR ligands in the local treatment of established intracerebral murine gliomasOliver M Grauer, Johan W Molling, Erik Bennink, et al.
Plos One|October 21, 2015
Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular MechanismsVerena Leidgens, Corinna Seliger, Birgit Jachnik, et al.
International Journal of Cancer|February 23, 2007
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivoOliver M Grauer, Stefan Nierkens, Erik Bennink, et al.
Frontiers in Immunology|December 24, 2021
The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke)Cristina Barca, Claudia Foray, Sven Hermann, et al.
Cancer Research and Treatment|July 27, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic LeukemiaMathias Lutz, Arik B Schulze, Elisabeth Rebber, et al.
International Journal of Cancer|December 14, 2007
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma modelOliver M Grauer, Roger P M Sutmuller, Wendy van Maren, et al.
Pageof 8